{"id":"https://openalex.org/W2107568445","doi":"https://doi.org/10.1016/s0041-008x(02)00079-0","title":"Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project","display_name":"Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project","publication_year":2003,"publication_date":"2003-03-01","ids":{"openalex":"https://openalex.org/W2107568445","doi":"https://doi.org/10.1016/s0041-008x(02)00079-0","mag":"2107568445","pmid":"https://pubmed.ncbi.nlm.nih.gov/12662897"},"language":"en","primary_location":{"id":"doi:10.1016/s0041-008x(02)00079-0","doi":"https://doi.org/10.1016/s0041-008x(02)00079-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0041-008x(02)00079-0","pdf_url":null,"source":{"id":"https://openalex.org/S42307217","display_name":"Toxicology and Applied Pharmacology","issn_l":"0041-008X","issn":["0041-008X","1096-0333"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology and Applied Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://orbi.umons.ac.be/handle/20.500.12907/7866","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028056295","display_name":"John C. Lindon","orcid":"https://orcid.org/0000-0002-0916-6360","observed_orcids":["https://orcid.org/0000-0002-0916-6360"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"John C Lindon","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, SW7 2AZ, London, UK. j.lindon@ic.ac.uk","Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, SW7 2AZ, London, UK. j.lindon@ic.ac.uk","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018207002","display_name":"Jeremy Kirk Nicholson","orcid":"https://orcid.org/0000-0002-8123-8349","observed_orcids":["https://orcid.org/0000-0002-8123-8349"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jeremy K Nicholson","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037616278","display_name":"Elaine C. Holmes","orcid":"https://orcid.org/0000-0002-0556-8389","observed_orcids":["https://orcid.org/0000-0002-0556-8389"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elaine Holmes","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006288795","display_name":"Henrik Antti","orcid":"https://orcid.org/0000-0003-1423-9517","observed_orcids":["https://orcid.org/0000-0003-1423-9517"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Henrik Antti","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057632393","display_name":"Mary E. Bollard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mary E Bollard","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042788986","display_name":"Hector C. Keun","orcid":"https://orcid.org/0000-0001-7358-8851","observed_orcids":["https://orcid.org/0000-0001-7358-8851"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hector Keun","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039963043","display_name":"Olaf P. Beckonert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Olaf Beckonert","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056339769","display_name":"Timothy M. D. Ebbels","orcid":"https://orcid.org/0000-0002-3372-8423","observed_orcids":["https://orcid.org/0000-0002-3372-8423"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy M Ebbels","raw_affiliation_strings":["Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Chemistry, Biomedical Sciences Division, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036472094","display_name":"Michael D. Reily","orcid":"https://orcid.org/0000-0003-1179-1525","observed_orcids":["https://orcid.org/0000-0003-1179-1525"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D Reily","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103673244","display_name":"Donald G. Robertson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald Robertson","raw_affiliation_strings":["Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, 2800 Plymouth Road, Ann Arbor, MI 48105, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046702136","display_name":"Gregory J. Stevens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory J Stevens","raw_affiliation_strings":["Pfizer Global R&D, La Jolla, CA, 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, La Jolla, CA, 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104067511","display_name":"Peter Luke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Luke","raw_affiliation_strings":["Pfizer Global R&D, Sandwich, Kent CT13 9NJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global R&D, Sandwich, Kent CT13 9NJ, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058442747","display_name":"Alan P. Breau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan P Breau","raw_affiliation_strings":["The Pharmacia Corporation, 4901 Searle Parkway, Skokie, IL 60077, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Pharmacia Corporation, 4901 Searle Parkway, Skokie, IL 60077, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111463656","display_name":"Glenn H. Cantor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Glenn H Cantor","raw_affiliation_strings":["The Pharmacia Corporation, 301 Henrietta St., Kalamazoo, MI 49007, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Pharmacia Corporation, 301 Henrietta St., Kalamazoo, MI 49007, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041800871","display_name":"Roy H. Bible","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roy H Bible","raw_affiliation_strings":["The Pharmacia Corporation, 4901 Searle Parkway, Skokie, IL 60077, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Pharmacia Corporation, 4901 Searle Parkway, Skokie, IL 60077, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Urs Niederhauser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Urs Niederhauser","raw_affiliation_strings":["Hoffmann-La Roche AG, Grenzacherstrasse, CH-4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche AG, Grenzacherstrasse, CH-4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111681794","display_name":"Hans Senn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Hans Senn","raw_affiliation_strings":["Hoffmann-La Roche AG, Grenzacherstrasse, CH-4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche AG, Grenzacherstrasse, CH-4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074813374","display_name":"G\u00f6tz Schlotterbeck","orcid":"https://orcid.org/0000-0002-9082-2846","observed_orcids":["https://orcid.org/0000-0002-9082-2846"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Goetz Schlotterbeck","raw_affiliation_strings":["Hoffmann-La Roche AG, Grenzacherstrasse, CH-4070 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche AG, Grenzacherstrasse, CH-4070 Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037124292","display_name":"Ulla Grove Sidelmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Ulla G Sidelmann","raw_affiliation_strings":["Novo Nordisk, Novo Nordisk Park, 2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk, Novo Nordisk Park, 2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074667915","display_name":"Steen M\u00f8ller Laursen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Steen M Laursen","raw_affiliation_strings":["Novo Nordisk, Novo Nordisk Park, 2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk, Novo Nordisk Park, 2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060596849","display_name":"Adrienne A. Tymiak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrienne Tymiak","raw_affiliation_strings":["Bristol-Myers Squibb Company, PO Box 4000, Princeton, NJ 08543, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Company, PO Box 4000, Princeton, NJ 08543, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001291631","display_name":"Bruce D. Car","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce D Car","raw_affiliation_strings":["Bristol-Myers Squibb Company, PO Box 4000, Princeton, NJ 08543, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Company, PO Box 4000, Princeton, NJ 08543, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029178085","display_name":"Lois D. Lehman\u2010McKeeman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lois Lehman-McKeeman","raw_affiliation_strings":["Bristol-Myers Squibb Company, PO Box 4000, Princeton, NJ 08543, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Company, PO Box 4000, Princeton, NJ 08543, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109949415","display_name":"Jean-Marie Colet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Marie Colet","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Co., Lilly Development Centre S.A., 1348 Mont-Saint-Guibert, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Lilly Development Centre S.A., 1348 Mont-Saint-Guibert, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051273765","display_name":"Ali Loukaci","orcid":"https://orcid.org/0000-0002-6180-0840","observed_orcids":["https://orcid.org/0000-0002-6180-0840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ali Loukaci","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Co., Lilly Development Centre S.A., 1348 Mont-Saint-Guibert, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Lilly Development Centre S.A., 1348 Mont-Saint-Guibert, Belgium","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108540548","display_name":"Craig E. Thomas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Craig Thomas","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Co., Lilly Development Centre S.A., 1348 Mont-Saint-Guibert, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Co., Lilly Development Centre S.A., 1348 Mont-Saint-Guibert, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5028056295"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":9.4334,"has_fulltext":false,"cited_by_count":385,"citation_normalized_percentile":{"value":0.99117026,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"187","issue":"3","first_page":"137","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metabolomics","display_name":"metabolomics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/xenobiotic-toxicity","display_name":"xenobiotic toxicity","score":0.925000011920929},{"id":"https://openalex.org/keywords/comet-project","display_name":"COMET project","score":0.7129999995231628},{"id":"https://openalex.org/keywords/1h-nmr-spectroscopy","display_name":"1H NMR","score":0.878000020980835},{"id":"https://openalex.org/keywords/toxicity-assessment","display_name":"toxicity prediction","score":0.5759999752044678},{"id":"https://openalex.org/keywords/expert-systems","display_name":"expert systems","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.9380000233650208},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hydrazine","display_name":"hydrazine","score":0.7020000219345093},{"id":"https://openalex.org/keywords/sample-consistency","display_name":"sample consistency","score":0.33500000834465027},{"id":"https://openalex.org/keywords/multivariate-statistical-models","display_name":"multivariate statistical models","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6010391116142273},{"id":"https://openalex.org/C33070731","wikidata":"https://www.wikidata.org/wiki/Q7218","display_name":"Toxicology","level":1,"score":0.5342884063720703},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4148312509059906},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38624289631843567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33888065814971924},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3215700387954712},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22852566838264465},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08726316690444946}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008660","descriptor_name":"Metabolism","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014116","descriptor_name":"Toxicology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D014116","descriptor_name":"Toxicology","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/s0041-008x(02)00079-0","doi":"https://doi.org/10.1016/s0041-008x(02)00079-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0041-008x(02)00079-0","pdf_url":null,"source":{"id":"https://openalex.org/S42307217","display_name":"Toxicology and Applied Pharmacology","issn_l":"0041-008X","issn":["0041-008X","1096-0333"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology and Applied Pharmacology","raw_type":"journal-article"},{"id":"pmid:12662897","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12662897","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology and applied pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:40842","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/40842","pdf_url":null,"source":{"id":"https://openalex.org/S4306400166","display_name":"Digital Access to Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800384882","host_organization_name":"Harris County Public Library","host_organization_lineage":["https://openalex.org/I2800384882"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Toxicology and Applied Pharmacology : for those working in the fields of toxicology, pharmacology, biochemistry, nutrition, veterinary medicine, Vol. 187, no. 3, p. 137-146 (2003)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:orbi.umons.ac.be:20.500.12907/7866","doi":null,"is_oa":true,"landing_page_url":"https://orbi.umons.ac.be/handle/20.500.12907/7866","pdf_url":null,"source":{"id":"https://openalex.org/S7407055454","display_name":"ORBi UMONS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Toxicology and Applied Pharmacology, 187 (3), 137-146 (2003-03-15)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"pmh:oai:orbi.umons.ac.be:20.500.12907/7866","doi":null,"is_oa":true,"landing_page_url":"https://orbi.umons.ac.be/handle/20.500.12907/7866","pdf_url":null,"source":{"id":"https://openalex.org/S7407055454","display_name":"ORBi UMONS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Toxicology and Applied Pharmacology, 187 (3), 137-146 (2003-03-15)","raw_type":"http://purl.org/coar/resource_type/c_6501"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1571862902","https://openalex.org/W1797956629","https://openalex.org/W1804875194","https://openalex.org/W1908647219","https://openalex.org/W1966854042","https://openalex.org/W1968813633","https://openalex.org/W1973363630","https://openalex.org/W1977018034","https://openalex.org/W1977030545","https://openalex.org/W1981939403","https://openalex.org/W1994358185","https://openalex.org/W2000563623","https://openalex.org/W2004746596","https://openalex.org/W2006248898","https://openalex.org/W2012638763","https://openalex.org/W2013607204","https://openalex.org/W2018675459","https://openalex.org/W2021551481","https://openalex.org/W2022906478","https://openalex.org/W2035398957","https://openalex.org/W2036373055","https://openalex.org/W2038097146","https://openalex.org/W2046325363","https://openalex.org/W2051186323","https://openalex.org/W2064741205","https://openalex.org/W2073441678","https://openalex.org/W2084608143","https://openalex.org/W2092906359","https://openalex.org/W2095442928","https://openalex.org/W2095449568","https://openalex.org/W2102770589","https://openalex.org/W2105299058","https://openalex.org/W2106383910","https://openalex.org/W2119878896","https://openalex.org/W2120407106","https://openalex.org/W2121817566","https://openalex.org/W2128879480","https://openalex.org/W2129314769","https://openalex.org/W2142105308","https://openalex.org/W2145880044","https://openalex.org/W2296148512","https://openalex.org/W2320546120","https://openalex.org/W2331759858","https://openalex.org/W2339475661","https://openalex.org/W2344279945","https://openalex.org/W2413570544","https://openalex.org/W2467458721"],"related_works":["https://openalex.org/W2123934362","https://openalex.org/W1969779341","https://openalex.org/W7133390104","https://openalex.org/W2091503195","https://openalex.org/W1992990387","https://openalex.org/W2007317723","https://openalex.org/W2167811642","https://openalex.org/W2046325363","https://openalex.org/W2018553398","https://openalex.org/W7039622459"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2016-06-24T00:00:00"}